Fecal Peritonitis in Rats

In this study, cecal ligation and puncture were performed in 75 Sprgue-Dawley rats. Peritoneal lavage was performed using 10 ml of povidone-iodine as 1% concentration in group A, while the same volume of 50% of honey diluted in distilled water was used in group B. Group C was used as a control. The overall mortality was 32% in group A (8/25), 12% in group B (3/25) and 60% in group C (15/25). Tissue toxicity was found to outweigh bactericidal effects. Honey was tested for its broad-spectrum antibacterial activity without adverse effects. So, we concluded that honey might be used as a peritoneal lavage solution with no side effects

Dermatological Lesions of Cholesterol Embolization Syndrome and Kaposi Sarcoma Mimic Primary Systemic Vasculitis: Case Report Study

Primary systemic vasculitis can present with a wide spectrum of manifestations ranging from systemic non-specific features such as fever, malaise, arthralgia, and myalgia to specific organ damage. We describe two cases of cholesterol embolization syndrome and Kaposi sarcoma mimicking primary systemic vasculitis, both of which were characterized by features such as livedo reticularis, blue toe syndrome, a brown, purpuric skin rash, and positive p-ANCA associated with Kaposi sarcoma. Establishing the right diagnosis was challenging, and thus we aim in this study to highlight the possible ways to distinguish them from primary systemic vasculitis. Keywords: Dermatological lesions, Cholesterol embolization syndrome, Kaposi sarcoma, vasculitis mimic

Enhanced thermal performance of closed-cell rigid Polyurethane (PU) foam panels using phase change materials (PCMs)

The consequences of extreme energy consumption are seen both in the energy and environmental crisis. Subsequently, researchers are attempting to find methods to address this issue. Building envelopes and insulation materials are elements that can effectively influence consumption through their passive effect on thermal comfort levels. Strategies pertaining to this that rely on both, advanced and traditional materials, have been able to show good potential. However, the technical complexity of using such strategies can be impeded from the perspective of developing countries. With the aim of creating effective low-cost feasible insulations through using methods of minimal intricacies, the potentials of simple amalgamation of materials are empirically investigated in this study. In this context, closed-cell rigid Polyurethane (PU) foam is used as a base to hold phase change materials (PCMs) to create two PU/PCM panels, of different PCM content. The thermal performance of the panels is experimentally examined and compared, with hot-arid climates prevailing in developing countries in mind. Results revealed that panels containing PCMs were able to perform more effectively in comparison with regular PU foam panels, and, that increasing the amount of PCM has also shown to be advantageous in this regard

Influence of Phase Change Materials (PCMs) on Polyurethane (PU) Foam Fire-Retardancy

Polyurethane (PU) foam is a material that has long been regarded as a good thermal insulator for building purposes due to many advantageous attributes, such as cost and feasibility. Yet, to further develop its performance, many studies have focused on the potential of using the micro-structure of PU foam as an encapsulation for PCMs. Despite the apparent advantageous outcome of this premise, from the perspective of thermal performance, fire-retardancy issues may pose as a threat. PU foam is known for its inherent poor fire-retardation properties. With the addition of PCMs, especially wax-based, it is possible that the fire-retardancy would worsen. This would translate into additional costs in terms of application of treatments to counter the disadvantageous hazardous properties. In this study, an empirical investigation is carried out with the aim of determining whether addition PCMs to PU foam would influence its retardation, and to which extent. In this context, granules of wax-based PCMs are encapsulated in to closed-cell rigid PU foam via a simplified amalgamation method. Two concentrations of PCM content are presented in this paper. Then, fire-retardancy testing is performed on specimens to compare the performance of the created PU/PCM specimens with this of regular PU specimens. The outcome of this empirical investigation further confirms that addition of PCM to PU foam is disadvantageous in terms of fire-retardancy, and that the amount of added PCM is of considerable influence on this

Design and synthesis of new thiazolidinone/uracil derivatives as antiproliferative agents targeting EGFR and/or BRAFV600E^{V600E}

Thiourea derivatives of uracil were efficiently synthesized via the reaction of 5-aminouracil with isothiocyanates. Then, we prepared uracil-containing thiazoles via condensation of thioureas with diethyl/dimethyl acetylenedicarboxylates. The structures of the products were confirmed by a combination of spectral techniques including infra-red (IR), nuclear magnetic resonance (NMR), mass spectrometry (MS) and elemental analyses. A rationale for the formation of the products is presented. The newly synthesized compounds were evaluated for their in vitro antiproliferative activity against four cancer cell lines. The compounds tested showed promising antiproliferative activity, with GI$_{50}$ values ranging from 1.10 µM to 10.00 µM. Compounds 3c, 5b, 5c, 5h, 5i, and 5j were the most potent derivatives, with GI$_{50}$ values ranging from 1.10 µM to 1.80 µM. Compound 5b showed potent inhibitory activity against EGFR and BRAF$^{V600E}$ with IC$_{50}$ of 91 ± 07 and 93 ± 08 nM, respectively, indicating that this compound could serve as a dual inhibitor of EGFR and BRAF$^{V600E}$ with promising antiproliferative properties. Docking computations revealed the great potency of compounds 5b and 5j towards EGFR and BRAF$^{V600E}$ with docking scores of −8.3 and −9.7 kcal/mol and −8.2 and −9.3 kcal/mol, respectively

Design, synthesis, docking and mechanistic studies of new thiazolyl/thiazolidinylpyrimidine-2,4-dione antiproliferative agents

In this article, we display on the synthesis and biological evaluation of a new series of thiazolylpyrimidine 3a-l and thiazolidinylpyrimidine derivatives 5a-e. The structures of the new compounds were confirmed by using different spectral techniques including NMR, IR, mass spectroscopy in addition to elemental analyses. The cell viability of the new compounds was assessed against normal human mammary gland epithelial (MCF-10A) cell line. Data revealed that none of the compounds examined exhibited cytotoxic effects, and the cell viability for the compounds examined at 50 µM was greater than 87%. The antiproliferative activity of 3a-l and 5a-e was evaluated against four human cancer cell lines where the compounds showed promising activity. The most potent derivatives were compounds 3a, 3c, 3f, 3i, and 5b with GI$_{50}$ values ranging from 0.90 µM to 1.70 µM against the four cancer cell lines in comparison to doxorubicin (GI$_{50}$ = 1.10 µM). Compounds 3a, 3c and 3i showed potent antiproliferative activity with dual inhibitory action against EGFR and BRAF$^{V600E}$. Compounds 3a, 3c, and 3i demonstrated promising AutoDock scores towards EGFR and BRAF$^{V600E}$ with values of − 9.1 and − 8.6, −9.0 and − 8.5, and − 8.4 and − 8.0 kcal/mol, respectively. The physicochemical and pharmacokinetic characteristics of 3a, 3c, and 3i were anticipated, demonstrating their oral bioavailability

Clinicopathological Significance of Vimentin and Cytokeratin Protein in the Genesis of Squamous Cell Carcinoma of Cervix

Cervical cancer is one of the commonest types of cancers worldwide especially in developing countries. Intermediate filaments protein family has shown a role in the diagnosis of various cancers, but a few studies are available about the vimentin and cytokeratin roles in the cervical cancer. This case control study aimed to interpret the expression of vimentin and cytokeratin proteins in the development and progression of cervical cancer and its correlation with clinicopathological features. The cytoplasmic expression of vimentin was observed in 40% of cases, but not in inflammatory lesions of cervix. It was noticed that vimentin expression was increasing significantly with high grade of the tumour. Cytokeratin expression was observed in 48.33% and it was noticed that the expression was 62.5% in well differentiated (G1), 45% in moderately differentiated (G2), and 41.66% in poorly differentiated carcinoma, yet statistically insignificant. The expression of vimentin and cytokeratin proteins was not significantly associated with age groups. The current findings concluded a possible role of vimentin in the development and progression of cervical cancer and vimentin marker will be useful in the diagnosis and grading of cervical cancer

A new variational approach to the stability of gravitational systems

We consider the three dimensional gravitational Vlasov Poisson system which describes the mechanical state of a stellar system subject to its own gravity. A well-known conjecture in astrophysics is that the steady state solutions which are nonincreasing functions of their microscopic energy are nonlinearly stable by the flow. This was proved at the linear level by several authors based on the pioneering work by Antonov in 1961. Since then, standard variational techniques based on concentration compactness methods as introduced by P.-L. Lions in 1983 have led to the nonlinear stability of subclasses of stationary solutions of ground state type. In this paper, inspired by pioneering works from the physics litterature (Lynden-Bell 94, Wiechen-Ziegler-Schindler MNRAS 88, Aly MNRAS 89), we use the monotonicity of the Hamiltonian under generalized symmetric rearrangement transformations to prove that non increasing steady solutions are local minimizer of the Hamiltonian under equimeasurable constraints, and extract compactness from suitable minimizing sequences. This implies the nonlinear stability of nonincreasing anisotropic steady states under radially symmetric perturbations

Quality control and beam test of GEM detectors for future upgrades of the CMS muon high rate region at the LHC

Gas Electron Multipliers (GEM) are a proven position sensitive gas detector technology which nowadays is becoming more widely used in High Energy Physics. GEMs offer an excellent spatial resolution and a high particle rate capability, with a close to 100% detection efficiency. In view of the high luminosity phase of the CERN Large Hadron Collider, these aforementioned features make GEMs suitable candidates for the future upgrades of the Compact Muon Solenoid (CMS) detector. In particular, the CMS GEM Collaboration proposes to cover the high-eta region of the muon system with large-area triple-GEM detectors, which have the ability to provide robust and redundant tracking and triggering functions. In this contribution, after a general introduction and overview of the project, the construction of full-size trapezoidal triple-GEM prototypes will be described in more detail. The procedures for the quality control of the GEM foils, including gain uniformity measurements with an x-ray source will be presented. In the past few years, several CMS triple-GEM prototype detectors were operated with test beams at the CERN SPS. The results of these test beam campaigns will be summarised

Global, regional, and national burden of chronic kidney disease, 1990–2017 : a systematic analysis for the Global Burden of Disease Study 2017

Background Health system planning requires careful assessment of chronic kidney disease (CKD) epidemiology, but data for morbidity and mortality of this disease are scarce or non-existent in many countries. We estimated the global, regional, and national burden of CKD, as well as the burden of cardiovascular disease and gout attributable to impaired kidney function, for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017. We use the term CKD to refer to the morbidity and mortality that can be directly attributed to all stages of CKD, and we use the term impaired kidney function to refer to the additional risk of CKD from cardiovascular disease and gout. Methods The main data sources we used were published literature, vital registration systems, end-stage kidney disease registries, and household surveys. Estimates of CKD burden were produced using a Cause of Death Ensemble model and a Bayesian meta-regression analytical tool, and included incidence, prevalence, years lived with disability, mortality, years of life lost, and disability-adjusted life-years (DALYs). A comparative risk assessment approach was used to estimate the proportion of cardiovascular diseases and gout burden attributable to impaired kidney function. Findings Globally, in 2017, 1·2 million (95% uncertainty interval [UI] 1·2 to 1·3) people died from CKD. The global all-age mortality rate from CKD increased 41·5% (95% UI 35·2 to 46·5) between 1990 and 2017, although there was no significant change in the age-standardised mortality rate (2·8%, −1·5 to 6·3). In 2017, 697·5 million (95% UI 649·2 to 752·0) cases of all-stage CKD were recorded, for a global prevalence of 9·1% (8·5 to 9·8). The global all-age prevalence of CKD increased 29·3% (95% UI 26·4 to 32·6) since 1990, whereas the age-standardised prevalence remained stable (1·2%, −1·1 to 3·5). CKD resulted in 35·8 million (95% UI 33·7 to 38·0) DALYs in 2017, with diabetic nephropathy accounting for almost a third of DALYs. Most of the burden of CKD was concentrated in the three lowest quintiles of Socio-demographic Index (SDI). In several regions, particularly Oceania, sub-Saharan Africa, and Latin America, the burden of CKD was much higher than expected for the level of development, whereas the disease burden in western, eastern, and central sub-Saharan Africa, east Asia, south Asia, central and eastern Europe, Australasia, and western Europe was lower than expected. 1·4 million (95% UI 1·2 to 1·6) cardiovascular disease-related deaths and 25·3 million (22·2 to 28·9) cardiovascular disease DALYs were attributable to impaired kidney function. Interpretation Kidney disease has a major effect on global health, both as a direct cause of global morbidity and mortality and as an important risk factor for cardiovascular disease. CKD is largely preventable and treatable and deserves greater attention in global health policy decision making, particularly in locations with low and middle SDI